Skip to content

REX American Resources

US · REX #3002 by market cap Listed 1970
44.31 +0.27 +0.61%
Live - 5344 symbols - heartbeat 516s ago · 2026-10-07 19:54
After-hours 44.31 0.00%
Market cap
1.47B
P/B
2.18
EPS
2.50
Reader sentiment Are you bullish or bearish on REX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
28.10 fair value ≈ 40.06 52.03
  • Implied fair-value range of 28.10-52.03, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +10.6% above the average-multiple fair value of 40.06.

Valuation each multiple against its own 5-year range

P/B ratio 2.17 Expensive vs history 90th percentile
5-year average 1.56 · #13 of 15 in Chemicals
P/E ratio 12.07 Cheap vs history 30th percentile
5-year average 16.02 · #2 of 5 in Chemicals
P/S ratio 2.22 Expensive vs history 93rd percentile
5-year average 1.12 · #16 of 16 in Chemicals

Vs. peers Chemicals

Company Market cap P/E (TTM) P/B Div yield
REX American Resources (REX) 1.47B 12.14 2.18 0.00%
Dow Inc (DOW) 20.06B -15.17 1.26 5.04%
Celanese Corp (CE) 4.81B -4.11 1.16 0.27%
Methanex (MEOH) 4.67B 63.59 1.82 1.22%
Olin (OLN) 1.81B -9.20 1.06 5.03%
Huntsman (HUN) 1.51B -8.22 0.56 5.94%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value45.79 Economic moatNone UncertaintyMedium

Trading 3.3% below Morningstar's fair value estimate.

Fair value

REX American Resources Corp receives a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 4% discount to our quantitative fair value estimate of $45.79 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The company's valuation metrics strengthen our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its price to cash ratio of 3.8, which sits in the bottom 40% compared with peers globally. Even if the company were to encounter financial distress, its cash balances could allow it to maneuver effectively. We believe this is a sign that shares could be undervalued.

The firm's balance sheet is an additional encouraging factor. Low leverage mitigates financial risk, potentially boosting a firm's value. The firm's current ratio of 6.9, for example, falls in the top 10% globally. We have little concern about this company's ability to cover near-term obligations, thanks to its relatively high current ratio; this could be a compelling signal during times of distress, which further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.

By Quantitative Equity Report

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.